Diagnosing Non–Producers Non–Secretory Myeloma


  • Nina Nurarifah Department of Internal Medicine, Universitas Brawijaya – RSUD Dr. Saiful Anwar Malang, Malang, East Java, Indonesia
  • Shinta Oktya Wardhani Department of Internal Medicine, Universitas Brawijaya – RSUD Dr. Saiful Anwar Malang, Malang, East Java, Indonesia




multiple myeloma, plasmacytoma, non secretory, non producers, lytic lesions


Multiple myelomas (MM) is the proliferation of malignant plasma cells in the bone marrow, characterized by the production of monoclonal immunoglobulins that are secreted in the blood and urine. However, in 1 - 5% of cases, the protein is undetectable and defined as non-secretory type of myeloma.

A 36-year-old woman presented with complaints of weakness in both legs so she could not walk. She also felt pain in the head, back, and thighs since one year before. Physical examination showed anemic conjunctiva, gibus as high as T4, hypoesthesia as high as T6 segment. She had anemia (Hb 10.2 g/dL), decreased kidney function (eGFR: 30 mL/min/1.73m2), and multiple lytic lesions in the calvaria, ribs, superior-inferior pubic ramus, and left humeral os in the 1/3 proximal to 1/3 distal. Protein electrophoresis and Bence Jonce protein were negative. There was no hypercalcemia, and bone marrow aspiration showed myelodysplasia syndrome. A thoracolumbar MRI showed an extradural solid mass and the histopathology examination result was plasmacytoma.

Non-secretory MM was defined into two groups, non-producers and multiple non-secretory myeloma patients who produce tumor proteins but cannot be excreted. This patients was categorized as non-producers non-secretory MM because she did not show a protein that can be measured in blood nor urine, but has significant plasma cells in tissue biopsy.

The absence of paraprotein in the blood does not rule out multiple myeloma. Suspicion of multiple myeloma needs to be increased in patients who have symptoms of CRAB (calcium, renal impairment, anemia, bone lytic).


Middela S, Kanse P. Nonsecretory multiple myeloma. Indian J Orthop [Internet]. India: Medknow Publications; 2009;43(4):408–11. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762556/

Smith DB, Harris M, Gowland E, Chang J, Scarffe JH. Non-secretory multiple myeloma: report of 13 cases with review of literature. Haematol Oncol. 1986;4:307–13.

Gray ST, Antunovic DM, White AE. Non secretory multiple myeloma involving the maxilla: report of a case with update of biology and new approaches to management. Oral Oncol. 1997 Mar; 33(2):136-40

Bladé J, Kyle R. Non-secretory multiple myeloma, immunoglobulin D myeloma, and plasma cell leukaemia. Haematol Oncol Clin North Am. 1999;13:1259–72.

Rubio-Felix D, Giralt M, Giraldo MP, Martinez-Peñuela JM, Oyarzabal F, Sala F, et al. Non-secretory multiple myeloma. Cancer. 1987;59:1847–52

Cavo M, Galieni P, Gobbi M, Baldrati L, Leardini L, Baccarani M, et al. Non-secretory multiple myeloma, presenting findings, clinical course and prognosis. Acta Haematol. 1985;74:27–30.

Kyle RA. Ask The Experts: Nonsecretory Myeloma. Myeloma Today. 2000;4:2.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma. NCCN Guidel. 2014;Version 2.

Lonial, Sagar; Kaufman JL. Non ­ Secretory Myeloma : A Clinician ’ s Guide Biology of Non ­ Secretory Myeloma. Oncology. 2015;1–6.

Syahrir M. Mieloma Multipel dan Penyakit Gamopati Lain. PAPDI: Buku Ajar Ilmu Penyakit Dalam. VI. Jakarta: InternaPublishing; 2014. p. 2700–7.

Society AC. Multiple Myeloma. Atlanta, USA; 2016

Supandiman, Iman. Sumantri, Rachmat. Fadjari, Heri. Irani, Panji. Oehadian A. Mieloma Multipel. Pedoman Diagnosis dan Terapi Hematologi Onkologi Medik. Bandung: Q-Communication; 2003. p. 70–7.

O’Connell TX, Horita TJ, Kasravi B. Understanding and interpreting serum protein electrophoresis. Am Fam Physician. 2005;71(1):105–12.

Graziani M, Merlini G, Petrini C. Guidelines for the analysis of Bence Jones protein. Clin Chem Lab Med. 2003;41(3):338–46




How to Cite

Nurarifah, N., & Wardhani, S. (2023). Diagnosing Non–Producers Non–Secretory Myeloma. Clinical and Research Journal in Internal Medicine, 4(1), 418–425. https://doi.org/10.21776/ub.crjim.2023.004.01.8